AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Losartan Potassium/Hydrochlorothiazide in Ghana
2 products registered with FDA Ghana — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| COLOSAR-DENK 100/12.5 TABLETS | UNKNOWN-3cd390e3 | — | active | 1 May 2030 |
| COLOSAR-DENK 100/12.5 TABLETS | UNKNOWN-266902c7 | — | active | 1 May 2030 |
Losartan Potassium/Hydrochlorothiazide — FDA Ghana Registration Details
FDA Ghana (Ghana) has 2 registered products containing Losartan Potassium/Hydrochlorothiazide, of which 2 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Losartan Potassium/Hydrochlorothiazide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.